Dr. Markus Zegke

Extreme chemist of nuclear chemistry

University of Cologne 2018

The institute, with its interdisciplinary team from the fields of radiochemistry, chemistry and biology, is engaged in the development and production of radioactive drugs for molecular imaging in oncology and neurology. It contributes to state-of-the-art diagnostics and personalized therapy for cancer, Alzheimer's and Parkinson's.